Lectures

Hyperlipidemia: Diagnosis and Management

by Charles Vega, MD
(1)

Questions about the lecture
My Notes
  • Required.
Save Cancel
    Learning Material 2
    • PDF
      Slides Hyperlipidemia ChronicCare.pdf
    • PDF
      Download Lecture Overview
    Report mistake

    About the Lecture

    The lecture Hyperlipidemia: Diagnosis and Management by Charles Vega, MD is from the course Chronic Care.


    Included Quiz Questions

    1. Switch to high dose rasuvastatin
    2. Decrease to moderate dose of atorvastatin
    3. Change to low dose simvastatin
    4. Terminate statin therapy completely to avoid further myalgias and complications
    5. Replace statin therapy with PCSK9 inhibitor therapy
    1. Screen for hyperlipidemia with a basic lipid panel
    2. No hyperlipidemia screening is required until the patient is 45 years old
    3. No hyperlipidemia screening is required until the patient is 35 years old
    4. Screen for hyperlipidemia only if her calculated 10 year cardiovascular risk is greater than 7.5%
    5. Screen for hyperlipidemia only if she has a family history of coronary heart disease or evidence of diabetes
    1. A 38-year-old female with a BMI of 22, blood pressure of 135/75, and no other significant past medical history or family history.
    2. A 21-year-old woman with a BMI of 21, normal vital signs, and no other medical problems, whose father had myocardial ischemia at the age of 59
    3. A 38-year-old man with a BMI of 23, blood pressure of 135/75, and no other significant past medical history or family history
    4. A 32-year-old man with a BMI of 27 who has a 4 pack year smoking history
    5. A 42-year-old woman with a BMI of 27 who has polycystic ovarian syndrome and a HBA1c of 6.5
    1. 15%
    2. 5%
    3. 18%
    4. 14%
    5. 30%
    1. 50%
    2. 30%
    3. 20%
    4. 15%
    5. 60%
    1. Consider checking lipid levels to assess for treatment adherence
    2. Monitor transaminase levels every 6 months while on high intensity statin therapy
    3. Monitor serum lipid levels every 4-6 months to check for efficacy
    4. Monitor serum lipid levels annually and adjust regimen accordingly
    5. Reassess 10 year cardiovascular risk score at least every 6 months

    Author of lecture Hyperlipidemia: Diagnosis and Management

     Charles Vega, MD

    Charles Vega, MD


    Customer reviews

    (1)
    5,0 of 5 stars
    5 Stars
    5
    4 Stars
    0
    3 Stars
    0
    2 Stars
    0
    1  Star
    0